MaxWin International Holdings (HKSE:08513) Research & Development: HK$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08513 MaxWin International Holdings Ltd HKSE:08513
53 GF Score
Price HK$0.33
GF Value HK$1.98
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is MaxWin International Holdings Research & Development?

MaxWin International Holdings HKSE:08513 +3.13% 53 Research & Development is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:08513 with a GF Score™ of 53/100 and a GF Value™ of HK$1.98 (Possible Value Trap). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. MaxWin International Holdings's Research & Development for the six months ended in Dec. 2025 was HK$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.0 Mil.

MaxWin International Holdings  (HKSE:08513) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

MaxWin International Holdings Research & Development Related Terms

MaxWin International Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for MaxWin International Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MaxWin International Holdings Research & Development Chart

MaxWin International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MaxWin International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:08513
53GF Score
MaxWin International Holdings Ltd HKSE:08513
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MaxWin International Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0.0 Mil mean?
MaxWin International Holdings (HKSE:08513) has a Research & Development of HK$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on MaxWin International Holdings and its competitors.
Is MaxWin International Holdings' Research & Development too high?
MaxWin International Holdings' current Research & Development is HK$0.0 Mil. Overall, MaxWin International Holdings has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MaxWin International Holdings' Research & Development compare to ISRG and BDX?
MaxWin International Holdings' Research & Development of HK$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on MaxWin International Holdings and its competitors. MaxWin International Holdings's current Research & Development is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MaxWin International Holdings stock overvalued right now?
Based on GuruFocus' analysis, MaxWin International Holdings (HKSE:08513) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.98, compared to a current price of HK$0.33 — trading 83.3% below its estimated fair value. The current Research & Development is HK$0.0 Mil. MaxWin International Holdings' overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For MaxWin International Holdings (HKSE:08513), the current Research & Development is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MaxWin International Holdings (HKSE:08513) Overvalued in 2026?

Based on GuruFocus' analysis, MaxWin International Holdings stock appears to be undervalued. The current stock price of HK$0.33 is trading 83.3% below its estimated GF Value™ of HK$1.98. GuruFocus considers MaxWin International Holdings to be Possible Value Trap.

Key valuation signals for HKSE:08513:

  • Research & Development: HK$0.0 Mil
  • GF Value™: HK$1.98 vs. price of HK$0.33 (83.3% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the HKSE:08513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MaxWin International Holdings Business Description

Address 16 Kallang Place, No. 02-10, Singapore, SGP, 339156
MaxWin International Holdings Ltd is engaged in the manufacturing and sale of injection molded plastic parts for disposable medical devices and the provision of tooling services in Singapore. The group also operates in data solutions and services involving IT-related products and maintenance services, as well as hospitality operations. It has four reportable segments: Component Parts, Sub-assembly Parts, Data Solutions and Services, and Hospitality. It generates the majority of its revenue from the Component Parts segment. Geographically, it generates the majority of its revenue from Mainland China.
53GF Score

Get the complete analysis for HKSE:08513

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.33
Price
HK$1.98
GF Value